The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials (2023)
- Authors:
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; ROSSI, GIORDANO NOVAK - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00406-022-01460-2
- Subjects: BIOMARCADORES; ANESTÉSICOS; ALUCINOGÊNICOS; DEPRESSÃO; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
- Keywords: Ketamine; Psychedelics; Treatment-resistant depression; Biomarkers
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European Archives of Psychiatry and Clinical Neuroscience
- ISSN: 0940-1334
- Volume/Número/Paginação/Ano: v. 273, n. 1, p. 129-155, 2023
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
ROSSI, Giordano Novak et al. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, v. 273, n. 1, p. 129-155, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-022-01460-2. Acesso em: 27 dez. 2025. -
APA
Rossi, G. N., Hallak, J. E. C., Baker, G., Dursun, S. M., & Santos, R. G. dos. (2023). The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials. European Archives of Psychiatry and Clinical Neuroscience, 273( 1), 129-155. doi:10.1007/s00406-022-01460-2 -
NLM
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s00406-022-01460-2 -
Vancouver
Rossi GN, Hallak JEC, Baker G, Dursun SM, Santos RG dos. The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 1): 129-155.[citado 2025 dez. 27 ] Available from: https://doi.org/10.1007/s00406-022-01460-2 - Classical hallucinogens as antidepressant drugs [Editorial]: a cautionary approach
- Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges
- Main targets of ibogaine and noribogaine associated with its putative anti-addictive effects: a mechanistic overview
- Tripping to cope: coping strategies and use of hallucinogens during the COVID-19 pandemic in three cultural contexts
- Longitudinal and transcultural assessment of the relationship between hallucinogens, well-being, and post-traumatic growth during the COVID-19 pandemic
- Molecular pathways of the therapeutic effects of Ayahuasca, a botanical psychedelic and potential rapid-acting antidepressant
- The use of classic hallucinogens/psychedelics in a therapeutic context: healthcare policy opportunities and challenges
- Cross-sectional associations between lifetime use of psychedelic drugs and psychometric measures during the COVID-19 confinement: a transcultural study
- Polypharmacology or “pharmacological promiscuity” in psychedelic research: what are we missing?
- Therapeutic use of serotoninergic hallucinogens: a review of the evidence and of the biological and psychological mechanisms
Informações sobre o DOI: 10.1007/s00406-022-01460-2 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003114668.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
